Furthermore, to examine the therapeutic effects of increased arginase-1 expression we decided to include a single dose of BCT-100, a pegylated recombinant arginase-1, as an in vivo therapy in a murine model of asthma (Figure 5A). This evidence concerns the gene ARG1 and asthma.